“A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 7, no. 1, June 2010, pp. 90-105, https://doi.org/10.32947/ajps.v7i1.321.